ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

TCBP TC BioPharm Holdings PLC

0,90
-0,0498 (-5,24%)
Pré-mercado
Última atualização: 05:43:26
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
TC BioPharm Holdings PLC TCBP NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,0498 -5,24% 0,90 05:43:26
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,9498
mais cotações »

Notícias Recentes

Data Hora Fonte Título
15/05/202409:30PRNUSTCBP Announces Launch of Compassionate Use Program for..
06/05/202414:01PRNUSTC BioPharm Announces Exercise of Warrants for £3.1 Million..
06/05/202409:30PRNUSTC BioPharm Announces Execution of Second Non-Binding Letter..
04/04/202409:32PRNUSTCBP Announces Execution of Non-Binding Letter of Intent for..
02/04/202409:30PRNUSTCBP Increasing Treatment Capacity with Expanded..
19/03/202409:30PRNUSTCBP Adjourns General Meeting Until a Later Date
18/03/202409:30PRNUSTCBP Announces Exercise of Series D Warrants For Cash
01/03/202410:30PRNUSBryan Kobel, CEO of TCBP, Appears on Nationally Syndicated..
27/02/202419:15PRNUS/C O R R E C T I O N -- TC BioPharm/
27/02/202410:30PRNUSTCBP Announces Shareholder Update Call on March 5th 2024
22/02/202411:32PRNUSTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK..
15/02/202410:30PRNUSTC BioPharm Management to Participate at Upcoming 7th..
14/02/202410:30PRNUSTCBP Provides Shareholder Update and Highlights Upcoming..
29/01/202410:30PRNUSTC BioPharm Chief Executive Officer, Bryan Kobel Featured on..
18/01/202410:30PRNUSTC BioPharm to Present at the Sequire Investor Summit
04/01/202410:30PRNUSTC BioPharm Regains Compliance with Nasdaq Minimum Bid Price..
03/01/202410:30PRNUSTC BioPharm Announces Additional Cost Reduction Steps to..
22/12/202310:30PRNUSTC BioPharm Announces Closing of $3.5 Million Public..
19/12/202310:00PRNUSTC BioPharm Announces Pricing of $3.5 Million Public..
18/12/202313:15PRNUSTC BioPharm Announces Formation of Commercial Development..
13/12/202308:30PRNUSTC BioPharm Announces Plan to Implement ADS Ratio Change
27/11/202310:45PRNUSTC BioPharm Announces FDA Clearance of Phase 1B IND for..
14/11/202312:00PRNUSTC BioPharm Announces Successful Completion of Safety Cohort..
02/11/202314:30PRNUSTC BioPharm Announces Streamlined Efficiencies and Reduces..
25/10/202309:00PRNUSTC BioPharm Selects Excellos as CDMO in Anticipation of..
23/10/202309:00PRNUSTC BioPharm Announces Submission of Investigational New Drug..
27/09/202309:00PRNUSTC BioPharm to Present at the LD Micro Main Event XVI
05/09/202309:30PRNUSTC BioPharm Announces Grant Funding in Collaboration with..
29/08/202309:30PRNUSTC BioPharm to Present at H.C. Wainwright 25th Annual Global..
31/07/202309:30PRNUSTC BioPharm Maintains Nasdaq Listing